Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the terminology transition appears above the page, and the footer revision advances from v3.7.1 to v3.7.2; the study record still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T01:01:40.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer's revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:06:30.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a '403 Forbidden' message and a Home button, replacing the previous study details and navigation. This blocks access to the trial information presented on that page.
    Difference
    17%
    Check dated 2026-09-23T01:11:13.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, indicating a new deployed version of the page. This change affects only deployment metadata, not the study details themselves.
    Difference
    0.0%
    Check dated 2026-09-16T00:07:53.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.6, replacing v3.6.5. This indicates a new build of the page without altering the study details.
    Difference
    0.0%
    Check dated 2026-09-01T19:12:59.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new NIH funding identifier, '2015 (U.S. NIH Grant/Contract)', was added to the study's identifiers on the Study Details page, documenting the funding source.
    Difference
    0.0%
    Check dated 2026-08-25T21:51:31.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.